Skip to content

Clinical trials

Phase 3 Lymphoma, Large B-Cell, Diffuse trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Country / region: Sweden Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20101
20111
20121
20132
20181
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Janssen Research & Development, LLC2
Arbeitsgemeinschaft medikamentoese Tumortherapie1
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
GlaxoSmithKline1
Hoffmann-La Roche1
Kite, A Gilead Company1
Lymphoma Study Association1
Nordic Lymphoma Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse14
Lymphoma, Non-Hodgkin5
Lymphoma4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Follicular3
Lymphoma, Mantle-Cell3
Neoplasms3
Recurrence3
Burkitt Lymphoma2
Lymphoma, B-Cell, Marginal Zone2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.